Transcutaneous immunization with pneumococcal surface protein A in mice

Transcutaneous immunization with phosphorylcholine induces antigen-specific mucosal and systemic immune responses in BALB/c mice

(2015) Hiromi Nagano et al.   AURIS NASUS LARYNX

“IDEAL” vaccines for resource poor settings

(2012) Myron M. Levine   VACCINE

Clinical study of transcutaneous vaccination using a hydrogel patch for tetanus and diphtheria

(2012) Sachiko Hirobe et al.   VACCINE

A Combination of Flt3 Ligand cDNA and CpG Oligodeoxynucleotide as Nasal Adjuvant Elicits Protective Secretory-IgA Immunity to Streptococcus pneumoniae in Aged Mice

(2011) Y. Fukuyama et al.   JOURNAL OF IMMUNOLOGY

Secretory-IgA Antibodies Play an Important Role in the Immunity to Streptococcus pneumoniae

(2010) Y. Fukuyama et al.   JOURNAL OF IMMUNOLOGY

Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates

(2009) Katherine L O'Brien et al.   LANCET

Intranasal immunization with a mixture of PspA and a Toll-like receptor agonist induces specific antibodies and enhances bacterial clearance in the airways of mice

(2009) Keita Oma et al.   VACCINE

Optimized Immune Response Elicited by a DNA Vaccine Expressing Pneumococcal Surface Protein A Is Characterized by a Balanced Immunoglobulin G1 (IgG1)/IgG2a Ratio and Proinflammatory Cytokine Production

(2008) D. M. Ferreira et al.   Clinical and Vaccine Immunology